UK Life Science Executives Discover Irvine’s Potential for US Expansion
Tuesday, November 05, 2019
More than a dozen executives from 11 U.K. life science companies visited Irvine for a three-day Irvine Life Science Showcase in October, which highlighted Irvine’s assets and the city’s strength as a medical technology and innovation hub. Out of the 11 companies, five have already made plans to revisit Irvine before the end of the year to further explore expansion in the city.
“The Chamber’s decision to encourage U.K. life science and technology companies to expand here is proving to be a very effective strategy on many levels,” said Linda DiMario, executive vice president of the Greater Irvine Chamber, who has spearheaded the foreign direct investment initiative. “Our inherent assets are augmented by business and community leadership who consistently deliver valuable time and resources to help these companies transition here.”
The Greater Irvine Chamber’s Showcase convened top executives from leading medical technology companies in the greater Irvine area, who provided one-on-one, pro bono consultations with the visiting U.K. executives. Through these meetings, executives from Adaptix Imaging, Axela, Cambridge Orthopaedic Labs Ltd, Elate Communications, Lantum, 3D LifePrints, OBRIZUM GROUP Ltd., Select Research, Sutrue, XenZone, and PxHealthcare were able to gain insights into Irvine’s life science sector, taxes, legal, logistics, HR, talent acquisition, regulatory matters, real estate, and many other areas in regard to doing business in Irvine.
“What stands out for me is the extra mile that everyone went to welcome us, and the opportunities that they wanted to share with us. There is such a strong commitment from your community to assist companies in their proposed set-up in Orange County,” said delegate Henry Pinchbeck, cofounder and CEO, 3D LifePrints. “I think that coming to the U.S. with Irvine as the first location will be transformational for 3D LifePrints; taking us from being an interesting U.K. company to a serious player in the medical device world.”
During their first day in Irvine, the U.K. executives joined more than 700 conference attendees at OCTANe’s Medical Technology Innovation Forum (MTIF), which focused on Southern California’s medical technology hub, personalized medicine, and personalized healthcare. The U.K. executives also had the opportunity to demonstrate their products and connect with medical technology professionals during the MTIF Innovation Showcase exhibition.
The conference was followed by a dinner for the delegates to meet with Irvine executives, Irvine Mayor Christina Shea, Greater Irvine Chamber President and CEO Bryan Starr, and Executive Vice President Linda DiMario.
The delegates toured Irvine medical technology and innovation organizations including 11 Health & Technologies, Allergan, Medtronic, UCI Applied Innovation, and University Lab Partners. At 11 Health & Technologies, they heard from Paul Gordon, vice president of global marketing for the U.K.-based company which expanded in Irvine, who described Irvine’s support network, workforce supply, and lifestyle, all components to keeping happy employees for long term sustainability.
The Greater Irvine Chamber coordinated and hosted a Hospital Engagement Breakfast at the Orange County Soccer Club where the delegates had the opportunity to connect with key executives from leading healthcare organizations in the region including Children’s Hospital of Orange County, Hoag Hospital, MemorialCare, and UCI Medical Center.
The Irvine READY! Reception at the Hive & Honey rooftop bar at the Irvine Spectrum Marriott offered the delegates a unique opportunity to make contact with more than 100 key Irvine executives while enjoying a sweeping, 360 view of the city.
See more photos:
For more information on the Chamber’s foreign direct investment work, contact Linda DiMario.
Category: Chamber News, Economic Development